Volatile Organic Compounds From Breath Differ Between Patients With Major Depression and Healthy Controls
- PMID: 35903642
- PMCID: PMC9314777
- DOI: 10.3389/fpsyt.2022.819607
Volatile Organic Compounds From Breath Differ Between Patients With Major Depression and Healthy Controls
Abstract
Major depressive disorder (MDD) is a widespread common disorder. Up to now, there are no easy and frequent to use non-invasive biomarkers that could guide the diagnosis and treatment of MDD. The aim of this study was to investigate whether there are different mass concentrations of volatile organic compounds (VOCs) in the exhaled breath between patients with MDD and healthy controls. For this purpose, patients with MDD according to DSM-V and healthy subjects were investigated. VOCs contained in the breath were collected immediately after awakening, after 30 min, and after 60 min in a respective breath sample and measured using PRT-MS (proton-transfer-reaction mass spectrometry). Concentrations of masses m/z 88, 89, and 90 were significantly decreased in patients with MDD compared with healthy controls. Moreover, changes during the time in mass concentrations of m/z 93 and 69 significantly differed between groups. Differentiation between groups was possible with an AUCs of 0.80-0.94 in ROC analyses. In this first study, VOCs differed between patients and controls, and therefore, might be a promising tool for future studies. Altered masses are conceivable with energy metabolism in a variety of biochemical processes and involvement of the brain-gut-lung-microbiome axis.
Keywords: biomarker; breath gas; classification; clinical utility; depression; volatile organic compounds.
Copyright © 2022 Lueno, Dobrowolny, Gescher, Gbaoui, Meyer-Lotz, Hoeschen and Frodl.
Conflict of interest statement
The authors obtained a patent for breath gas analysis in major depressive disorder. Thus, there is no embargo for the publication any more. TF received fees for presentation from Janssen-Cilag, Servier, Neuraxpharm, Recordati, and Otsuka. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Dynamic Stability of Volatile Organic Compounds in Respiratory Air in Schizophrenic Patients and Its Potential Predicting Efficacy of TAAR Agonists.Molecules. 2023 May 27;28(11):4385. doi: 10.3390/molecules28114385. Molecules. 2023. PMID: 37298866 Free PMC article.
-
Gut-brain axis volatile organic compounds derived from breath distinguish between schizophrenia and major depressive disorder.J Psychiatry Neurosci. 2023 Apr 12;48(2):E117-E125. doi: 10.1503/jpn.220139. Print 2023 Mar-Apr. J Psychiatry Neurosci. 2023. PMID: 37045476 Free PMC article.
-
Volatile organic compounds from exhaled breath in schizophrenia.World J Biol Psychiatry. 2022 Dec;23(10):773-784. doi: 10.1080/15622975.2022.2040052. Epub 2022 Mar 9. World J Biol Psychiatry. 2022. PMID: 35171077
-
Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.Ann Pharm Fr. 2013 Jul;71(4):203-15. doi: 10.1016/j.pharma.2013.05.002. Epub 2013 Jun 17. Ann Pharm Fr. 2013. PMID: 23835018 Review.
-
Utility of volatile organic compounds as a diagnostic tool in preterm infants.Pediatr Res. 2021 Jan;89(2):263-268. doi: 10.1038/s41390-020-0828-3. Epub 2020 Mar 2. Pediatr Res. 2021. PMID: 32120380
Cited by
-
A novel set of volatile urinary biomarkers for late-life major depressive and anxiety disorders upon the progression of frailty: a pilot study.Discov Ment Health. 2022 Oct 27;2(1):20. doi: 10.1007/s44192-022-00023-0. Discov Ment Health. 2022. PMID: 37861875 Free PMC article.
-
Breathomics profiling of metabolic pathways affected by major depression: Possibilities and limitations.Front Psychiatry. 2022 Dec 14;13:1061326. doi: 10.3389/fpsyt.2022.1061326. eCollection 2022. Front Psychiatry. 2022. PMID: 36590606 Free PMC article.
-
Recent Progress in Mass Spectrometry-Based Metabolomics in Major Depressive Disorder Research.Molecules. 2023 Nov 4;28(21):7430. doi: 10.3390/molecules28217430. Molecules. 2023. PMID: 37959849 Free PMC article. Review.
-
Dynamic Stability of Volatile Organic Compounds in Respiratory Air in Schizophrenic Patients and Its Potential Predicting Efficacy of TAAR Agonists.Molecules. 2023 May 27;28(11):4385. doi: 10.3390/molecules28114385. Molecules. 2023. PMID: 37298866 Free PMC article.
-
Association between volatile organic compounds exposure and infertility risk among American women aged 18-45 years from NHANES 2013-2020.Sci Rep. 2024 Dec 28;14(1):30711. doi: 10.1038/s41598-024-80277-6. Sci Rep. 2024. PMID: 39730403 Free PMC article.
References
-
- Enache D, Pariante CM, Mondelli V. Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun. (2019) 81:24–40. 10.1016/j.bbi.2019.06.015 - DOI - PubMed
LinkOut - more resources
Full Text Sources